U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07179055) titled 'An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye' on Sept. 10.
Brief Summary: The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Dry Eye
Intervention:
DRUG: VSJ-110
ophthalmic solution
DRUG: Placebo
ophthalmic solution
Recruitment Status: RECRUITING
Sponsor: Vanda Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....